Dr. Hammad Nasir Qureshi, MD

Dr. Qureshi practices at Texas Children's Hospital - Mfm the Methodist Hospital - HOPD in Houston, Texas.

Dr. Qureshi's NPI, 1063618874, was assigned on June 27, 2007. Dr. Qureshi graduated from King Edward Medical University in 2004. Dr. Qureshi's Texas license number on file is N7163.

Dr. Qureshi's primary practice is Texas Children's Hospital - Mfm the Methodist Hospital - HOPD, at 6550 Fannin St, Houston, TX 77030.

Dr. Qureshi's primary practice is Texas Children's Hospital - Mfm the Methodist Hospital - HOPD in Houston, Texas. Dr. Qureshi is also affiliated with Houston Methodist Hospital. The medical group on file is Houston Methodist Specialty Physician Group. Dmand AI also links Dr. Qureshi to 3 more hospitals, 5 group practices and clinics and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Qureshi practices, 10 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Qureshi's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Qureshi is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Qureshi's licenses on file in 2 states: Texas and Illinois.

Dmand AI lists aneurysm, asthma, bronchitis, chronic hypertension, chronic lung disease, chronic nasal allergies, chronic obstructive pulmonary disease (COPD) and chronic respiratory failure among the conditions Dr. Qureshi treats.

CMS data shows 4,835 Medicare services from Dr. Qureshi across 21 procedure codes in 2024, for 975 Medicare patients. Medicare paid $289,043 for them.

CMS counts 975 Medicare patients who saw Dr. Qureshi in 2024. The largest group is 65 to 74, with 402 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 2.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Qureshi's median patient age at 73, with 57% women.

In 2024, Dr. Qureshi wrote 4,613 Medicare Part D claims for 732 patients. 55% of them were for generic drugs. CMS names the drug for 4,350 of them, across 46 drugs with 11 or more claims each, at $1,980,599 in total drug cost. In 2023, CMS named 3,915 claims across 40 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Qureshi for performance year 2024, reported individually. Dr. Qureshi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Qureshi as offering telehealth.

Dmand AI links 2 papers to Dr. Qureshi. Dr. Qureshi's most frequent co-authors are Nicola A. Hanania, MD and Amir Sharafkhaneh, MD, PhD.

CMS Open Payments shows 900 general payments to Dr. Qureshi from 61 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 64% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $39,761.

Dr. Qureshi graduated from King Edward Medical University in 2004.

Dr. Qureshi is in network with 21 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.